Bli medlem
Bli medlem

Du är här

2020-08-12

STENOCARE shares traded on the Börse Berlin

Germany legalized medical cannabis in 2017 and is currently one of Europe's largest medical cannabis markets. STENOCARE's management is therefore positive about the company's shares being included at the Börse Berlin, which will provide the company with increased access to German investors. As has previously been announced, STENOCARE has considered alternatives for co-trading in other international markets, as a way of responding to requests from international investors. The trading at the Börse Berlin's BSRM (Berlin Second Regulated Market), albeit not on STENOCARE's own initiative, is therefore in line with the company's plans and could contribute to a broader interest in STENOCARE.

Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments:

"It is certainly a good sign that we have now been informed about STENOCARE's share being added to the Börse Berlin, which will provide us with increased visibility and access to German investors. We continue to prepare and roll-out our strategy for wider European market leadership and look forward to welcoming new shareholders from Germany and other European countries".

Författare STENOCARE

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.